Transjugular Intrahepatic Portosystemic Shunt with an Autologous Vein–Covered Stent: Results in a Swine Model

To investigate the feasibility, safety, and efficacy of an autologous vein–covered stent (AVCS) to prevent shunt stenosis in a porcine transjugular intrahepatic portosystemic shunt (TIPS) model. TIPS were created with an AVCS in 12 healthy domestic swine and with a bare stent in 10 additional swine....

Full description

Saved in:
Bibliographic Details
Published inJournal of vascular and interventional radiology Vol. 12; no. 11; pp. 1333 - 1342
Main Authors Zhuang, Zhen W., Hoopes, P. Jack, Koutras, Paul C., Ebbighausen, Wanda H., Wagner, Robert J., Bettmann, Michael A.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2001
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To investigate the feasibility, safety, and efficacy of an autologous vein–covered stent (AVCS) to prevent shunt stenosis in a porcine transjugular intrahepatic portosystemic shunt (TIPS) model. TIPS were created with an AVCS in 12 healthy domestic swine and with a bare stent in 10 additional swine. Tissue response was compared with use of venography, histology, and computerized morphometry analysis 2 weeks after implantation. Differences between AVCS and noncovered stents (established by a t-test), as well as regional differences within a single stent (established by an f test), were considered significant at P < .05. Twenty of 22 TIPS procedures were technically successful. Ten of 12 shunts with an AVCS (83%) and two of 10 with bare stents (20%) remained patent (<50% diameter narrowing) at euthanasia 2 weeks later ( P < .01). Histologic evaluation of harvested bare stents showed marked intimal hyperplasia (IH), composed of smooth muscle cells, myofibroblasts, and fibroblasts. In contrast, the AVCS were remarkably free of IH and thromboses. In patent TIPS in both groups, endothelial coverage of the luminal surface was present histologically. IH accounted for 57% (26.27/45.79) of total stent cross-sectional lumen area in the control group and 21% (8.34/39.54) in the AVCS group ( P < .01), with no intrashunt differences ( P > .05). Based on short-term follow-up, AVCS significantly improved TIPS patency by prevention of both IH and in-stent thrombosis. TIPS created with an AVCS was feasible and safe in our porcine model.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1051-0443
1535-7732
DOI:10.1016/S1051-0443(07)61560-7